Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Systematic Review

Published on 06 Jan 2025

A bibliometric analysis of 30 years of research on transarterial radioembolization (TARE) for hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Tongyao Hu
Qifan Xu
Guorong Jia
Tao Wang
Changjing Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1449722

1,348 views

Hypothesis and Theory

Published on 06 Jan 2025

Clinical significance of lipid pathway-targeted therapy in breast cancer

in Pharmacology of Anti-Cancer Drugs

Dan Li
Pengcheng Jin
Yiqi Cai
Shijie Wu
Xianan Guo
Zhiyun Zhang
Kexin Liu
Panni Li
Yue Hu
Yunxiang Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1514811

912 views

Review

Published on 06 Jan 2025

Regulation and therapy: the role of ferroptosis in DLBCL

in Pharmacology of Anti-Cancer Drugs

Yifan Wang
Zhengmei He
Xinyu Dong
Yiming Yao
Qiuni Chen
Yuye Shi
Yuan Deng
Quane Zhang
Liang Yu
Chunling Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1458412

1,347 views

Review

Published on 03 Jan 2025

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges

in Pharmacology of Anti-Cancer Drugs

Sofija Kozarac
Jelena Ivanovic
Marko Mitrovic
Kristina Tomic Vujovic
Isidora Arsenovic
Nada Suvajdzic-Vukovic
Andrija Bogdanovic
Ana Vidovic
Milena Todorovic-Balint
Jelena Bila

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517972

1,642 views

Original Research

Published on 03 Jan 2025

Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties

in Pharmacology of Anti-Cancer Drugs

Wisam Taher Muslim
Layth Jasim Mohammad
Munaf M. Naji
Isaac Karimi
Matheel D. Al-Sabti
Majid Jabir
Mazin A. A. Najm
Helgi B. Schiöth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511627

1,241 views

Original Research

Published on 19 Dec 2024

ABCA1 promote tumor environment heterogeneity via epithelial mesenchymal transition in Huh7 and HepG2 liver cancer cell

in Pharmacology of Anti-Cancer Drugs

Dinglai Yu
Fang Guo
Qiyu Zhang
Huajun Yu
Wenmin Wang
Yunzhi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498528

1,078 views

Original Research

Published on 18 Dec 2024

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC

in Pharmacology of Anti-Cancer Drugs

Xue Li
Shimin Chen
Yuanyuan Shi
Yuanjing Wang
Xuanzhe Wang
Qian Lin
Chao Wu
Wenshuo Fang
Peng Sun
Leina Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464852

1,608 views

Review

Published on 18 Dec 2024

Metabolic reprogramming in lung cancer and its clinical implication

in Pharmacology of Anti-Cancer Drugs

Qingqiu Huang
Lisha Fan
Mingjing Gong
Juntong Ren
Chen Chen
Shenglong Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516650

1,373 views
1 citation

Editorial

Published on 18 Dec 2024

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, Volume II

in Pharmacology of Anti-Cancer Drugs

Yan Zhang
Leilei Fu
Muhammad Umer Farooq Awan
Yinu Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519858

522 views

Original Research

Published on 18 Dec 2024

Development and validation of a programmed cell death index to predict the prognosis and drug sensitivity of gastric cancer

in Pharmacology of Anti-Cancer Drugs

Feizhi Lin
Xiaojiang Chen
Chengcai Liang
Ruopeng Zhang
Guoming Chen
Ziqi Zheng
Bowen Huang
Chengzhi Wei
Zhoukai Zhao
Feiyang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477363

938 views

Original Research

Published on 13 Dec 2024

β-caryophyllene sensitizes hepatocellular carcinoma cells to chemotherapeutics and inhibits cell malignancy through targeting MAPK signaling pathway

in Pharmacology of Anti-Cancer Drugs

Irum Basheer
Hai Wang
Guangyue Li
Shah Jehan
Ali Raza
Chentao Du
Najeeb Ullah
Dangdang Li
Guangchao Sui

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1492670

1,495 views
1 citation

Correction

Published on 13 Dec 2024

Corrigendum: Role of β-interferon inducer (DEAE-Dextran) in tumorigenesis by VEGF and NOTCH1 inhibition along with apoptosis induction

in Pharmacology of Anti-Cancer Drugs

Anita K. Bakrania
Bhavesh C. Variya
Snehal S. Patel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433625

492 views

Mini Review

Published on 11 Dec 2024

Cellular components of tumor microenvironment: understanding their role in lymphatic metastasis of tumors

in Pharmacology of Anti-Cancer Drugs

Ziyi Wang
Zehui Li
Xiangyu Sun
Wanfu Men
Yan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463538

1,121 views

Review

Published on 11 Dec 2024

NGF-mediated crosstalk: unraveling the influence of metabolic deregulation on the interplay between neural and pancreatic cancer cells and its impact on patient outcomes

in Pharmacology of Anti-Cancer Drugs

Francesca Trentini
Virginia Agnetti
Martina Manini
Elisa Giovannetti
Ingrid Garajová

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499414

1,129 views

Original Research

Published on 11 Dec 2024

Ailanthone blocks mitophagy to promote mtDNA leakage through BAX-BAK1 pores and suppress hepatocellular carcinoma cell proliferation

in Pharmacology of Anti-Cancer Drugs

Yan Qin
Ying Gao
Dan Wu
Qing-Qing Liu
Chang Su
Guan Liu
Le Yang
Ming-Gao Zhao
Jing-Yue Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509482

1,358 views

Case Report

Published on 10 Dec 2024

Case report: Therapeutic response to lorlatinib in advanced large-cell neuroendocrine carcinoma of the lung and breast cancer: a heterochronous double malignancy perspective

in Pharmacology of Anti-Cancer Drugs

Xiaoli Mu
Yan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413897

1,010 views